with how QC Ware uses the data we collect from you when you use our
Q2B event platform.
This presentation will cover Boehringer-Ingelheim’s thesis on quantum computing, our program composition, partners, and work completed so far. We will also discuss the potential applications of quantum computing in drug discovery and development, as well as the current limitations and future prospects of the technology. The presentation also highlights the need for collaboration between academia, industry, and government to fully harness the power of quantum computing in life science.
Clemens Utschig-Utschig, CTO, Boehringer-Ingelheim
Sign Up For Updates
By completing this form you agree with the storage and handling of your data by QC Ware. You are signing up to receive updates regarding QC Ware, its products, and/or events hosted by the company. If you do not select a specific type of updates to receive, you will subscribe to receive all company updates.